Chikujee Therapeutics, is an innovative biopharmaceutical company committed to the development and commercialization of nanotechnology based cancer therapies that address unmet needs in the treatment of cancer. Chikujee’s NanoBindi- multifunctional nanoparticle based product engine forms the foundation for a robust oncology product pipeline, with each product candidate having a distinct functional profile and representing a unique opportunity for integrated cancer therapeutic management.
At Chikujee, our approach to innovation extends beyond that of many biotechnology companies. In addition to considering the possibilities for new medicines at the nano level, we go a step further: we apply our innovative science with a thoughtful focus on patients’ real-world needs and behaviors.